RenovoRx grants Macfarlane 55,924 stock options

The award vests in 12 equal monthly installments beginning November 1, 2026, and the options expire October 1, 2036.

Rhea-AI Filing Summary

RenovoRx, Inc. director K. Angela Macfarlane received a grant of 55,924 stock options on October 1, 2026, bringing her reported post-transaction position to 55,924 options. The options are exercisable at $1.55 per share for RenovoRx common stock. They vest in 12 equal monthly installments beginning November 1, 2026, and expire October 1, 2036.

Insider Trade Summary

Grant/Award: 55,924 shares

Grant/Award 1 txn

Insider Macfarlane K. Angela

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (right to buy) F1	55,924	$0.00	$0.00

Holdings After Transaction: Stock Options (right to buy) — 55,924 contracts (Direct)

Footnotes (1)

1. F1. The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2026.

Key Figures

Stock options awarded: 55,924 options Post-transaction position: 55,924 options Exercise price: $1.55 per share +2 more

5 metrics

Stock options awarded 55,924 options Grant to K. Angela Macfarlane on October 1, 2026

Post-transaction position 55,924 options Reported position after the grant

Exercise price $1.55 per share For RenovoRx common stock

Vesting schedule 12 equal monthly installments Beginning November 1, 2026

Expiration date October 1, 2036 Stock options

Key Terms

Stock Options (right to buy), exercise price, monthly installments

3 terms

Stock Options (right to buy) financial

"Stock Options (right to buy)"

exercise price financial

"conversion or exercise price of $1.55"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

monthly installments financial

"vest in 12 equal monthly installments"

Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many stock options did RenovoRx director K. Angela Macfarlane receive?

K. Angela Macfarlane received a grant of 55,924 stock options on October 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 05:01 PM Accepted by SEC EDGAR 10/02/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Macfarlane K. Angela

(Last) (First) (Middle)

C/O RENOVORX, INC.

2570 W EL CAMINO REAL, SUITE 640

(Street)

MOUNTAIN VIEW CALIFORNIA 94040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	$1.55	10/01/2026		A		55,924		(1)	10/01/2036	Common Stock	55,924	$0	55,924	D

Explanation of Responses:

1. The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2026.

	/s/ K. Angela Macfarlane	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)